FindTrial
Sign In

Study on the mechanism of amphiregulin promoting oral squamous cell carcinoma metastasis via vascular mimicry

Study on the mechanism of amphiregulin promoting oral squamous cell carcinoma metastasis via vascular mimicry

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300075301
Enrollment
Unknown
Registered
2023-08-31
Start date
2023-09-01
Completion date
Unknown
Last updated
2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

oral squamous cell carcinoma (OSCC)

Interventions

Group of oral squamous cell carcinoma:NA

Sponsors

Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients with pathological diagnosis of oral squamous cell carcinoma. All patients voluntarily undergo surgical treatment and sign an informed consent form.

Exclusion criteria

Exclusion criteria: Patients with pathological diagnosis of non-OSCC, or OSCC patients who have received radiotherapy, chemotherapy, targeted therapy, or immunotherapy

Design outcomes

Primary

MeasureTime frame
amphiregulin concentration;—

Countries

China

Contacts

Public ContactChuanxia Liu

Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine

0014806@zju.edu.cn+86 157 0010 6621

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026